Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase IV, open, non-randomised, multicentre study to assess the reactogenicity and immunogenicity of a booster dose of GSK Biologicals’ combined reduced-antigen-content diphtheria-tetanus, acellular pertussis and inactivated poliovirus vaccine dTpa-IPV (Boostrix-Polio) when administered in healthy subjects aged 9-13 years, 5 years after previous booster vaccination with dTpa-IPV in the study 711866/001 (dTpa-IPV-001) https://kusajili.com:443/Trial/AmdIioSu4kyTCE9BdaGriA%24a-phase-iv-open-non-randomised-multicentre-study-to-assess-the-reactogenicity-and-immunogenicity-of-a-booster-dose-of-gsk-biolo
I have read and accept the terms of use of the site and the Privacy Policy
Send your message